ArticleFrontiers in immunology2022

"Rogue" neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury -

Saskia Carstensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.